A recent study examined real-world data to confirm the survival benefit of lung cancer screening. Learn more in The Week in Cancer News from Zodiac Signs Magazine:
bit.ly/3VoyIoI

The U.S. FDA approved the immune checkpoint inhibitor durvalumab with chemotherapies carboplatin plus paclitaxel followed by single-agent durvalumab for some adult patients with endometrial cancer that is mismatch repair deficient: bit.ly/3xgbhpG

June is #NationalCancerSurvivorMonth . Cancer survivors face a host of psychological challenges, which necessitate approaches that improve the mental well-being of this population. Learn more in the AACR #CancerProgressReport :
bit.ly/4clTKeI

Register by August 8 to get the lowest available rates for the AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved (September 21-24, Los Angeles). Learn more:
bit.ly/3xigwFc
#AACRdisp24 #AACRMICR Melissa B Davis, PhD

Submit an abstract by June 18 for the Ovarian Cancer Research Symposium (September 20-21, Seattle), presented by the Rivkin Center and the AACR. Learn more:
bit.ly/3VHDO0I

Join us on June 24 at 12:30 pm ET for a free interactive roundtable discussion of the AACR Cancer Disparities Progress Report 2024. Learn more and register for this virtual event: bit.ly/3Xpp1sW #CancerDisparitiesReport

'An unparalleled educational experience, providing invaluable drug development knowledge that simply cannot be found elsewhere!'
—2022-23 FDA-AACR Oncology Educational Fellow Lei Deng, MD (He/Him)
Apply by August 1 to join the next class of fellows:
bit.ly/3Xjen6U
#AACRSciencePolicy

KRAS Resistance, Mechanisms, and Therapeutics:
Andrew Aguirre, Kenneth P. Olive, and Mallika Singh will address this topic in a plenary session at the AACR Conference on Advances in Pancreatic Cancer Research (Sept 15-18, Boston).
bit.ly/4el6lAu
#AACRpan24 KenOliveLab

Register by June 21 for virtual access to the Eighth JCA-AACR Special Joint Conference on The Molecular Renaissance in Colorectal Cancer (June 28-30), chaired by Luis A. Diaz and Koshi Mimori. Learn more:
bit.ly/45mOYLw

The Fanconi Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research is a three-year, $450,000 grant that supports early-career investigators conducting creative, paradigm-shifting Fanconi anemia-associated cancer research. Apply by July 9:
bit.ly/3VqB5r0

#AACRsynth24 cochairs Stegmaier Lab, Alejandro Sweet-Cordero, MD, Michael Erb, and Kris C. Wood closed the AACR Special Conference on Cancer Synthetic Vulnerabilities this afternoon in Montreal. We thank the cochairs for developing an outstanding meeting. Sweet-Cordero Lab @ UCSF Kris Wood

Today, the U.S. FDA granted accelerated approval for the targeted therapy repotrectinib for some adult and pediatric patients 12 years and older with NTRK gene fusion-positive solid tumors: bit.ly/3XhZPo7

Jolanta E. Grembecka, Serena J. Silver, Karen M. Cichowski, Janice Y. Lee, and Nadja Zhakula discussed 'Translating the Next Synthetic Lethalities' in a plenary session at the AACR Conference on Cancer Synthetic Vulnerabilities. #AACRsynth24

The AACR Distinguished Lectureship in Breast Cancer Research recognizes science that has inspired, or has potential to inspire, new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer. Nominate a colleague by June 17:
bit.ly/4b7hPVo

New Technologies to Discover Synthetic Lethality: Luke A. Gilbert, Francisco J. Sánchez Rivera, Kristen L. Karlin, Jorge A. Alfaro-Murillo, and Rand Arafeh addressed this topic in a plenary at the AACR Conference on Cancer Synthetic Vulnerabilities. #AACRsynth24 LukeGilbert

Submit an abstract by June 18 for the AACR Conference on Pediatric Cancer (Sept 5-8, Toronto), chaired by Alejandro Gutierrez, Cynthia E. Hawkins, Andrea A. Hayes, and Gilles Vassal.
bit.ly/4ejf7yZ
#AACRpediatric24 Alejandro Gutierrez Hawkins Lab Andrea A. Hayes, MD Gilles Vassal

Submit an abstract by June 26 for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (October 23-25, Barcelona, Spain), chaired by E.G. Elisabeth de Vries, Tim F. Greten, and Timothy A. Yap.
bit.ly/3KMybb6
#ENASymp24 Elisabeth de Vries Tim Greten

The AACR is proud to support U.S. FDA’s National Black Family Cancer Awareness Week (June 13-19), which raises awareness about the impact of cancer on Black families and fosters minority participation in clinical trials. bit.ly/4aVKUDa #BlackFamCan